Sotera Health (SHC) Cost of Revenue (2020 - 2026)

Sotera Health (SHC) has reported Cost of Revenue for 7 consecutive years, with $133.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 11.66% year-over-year to $133.0 million; the TTM figure through Mar 2026 stood at $532.0 million (up 7.21% YoY), while the FY2025 annual figure was $518.1 million, up 4.0% from the prior year.
• Cost of Revenue came in at $133.0 million for Q1 2026 at Sotera Health, down from $137.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $137.5 million in Q4 2025, with the low at $107.9 million in Q1 2022.
• Average Cost of Revenue over 5 years is $121.6 million, with a median of $121.1 million recorded in 2024.
• Across the five-year window, Cost of Revenue increased 18.46% in 2023 and retreated 3.32% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $109.9 million in 2022, then gained by 18.46% to $130.2 million in 2023, then retreated by 3.32% to $125.8 million in 2024, then rose by 9.28% to $137.5 million in 2025, then decreased by 3.3% to $133.0 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $133.0 million, $137.5 million, and $133.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.